TSM 3.77JPM 1.92CP.TO 0.63ZST.TO 0.02HSAV.TO -0.1HSUV.U.TO 0.01AEO 0.09AVAV -7.9
MoonLake Immunotherapeutics (MLTX)

NASDAQ:MLTX

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.

12.73
-0.45 (3.41%)
as of Sep 11, 2026, 4:01:19 pm Market Open.
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

MoonLake Immunotherapeutics(MLTX)

Oct 02, 2025
Financial Highlights for MoonLake Immunotherapeutics in Q2 '25. Gross Profit stood at -740,000, marking a -96.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Cost of Revenue was 740,000, a 96.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations. Social media mentions are up 59.1% in the past 24h.

 MoonLake Immunotherapeutics

Photo of The Weekly Buzzing Stocks by Billy KawasakiThe Weekly Buzzing Stocks by Billy Kawasaki
$7.36

Stock price when the opinion was issued

$12.73

As of Sep 11, 2026. Market Open.

Healthcare
premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

MoonLake Immunotherapeutics(MLTX)

Oct 02, 2025

Financial Highlights for MoonLake Immunotherapeutics in Q2 '25. Gross Profit stood at -740,000, marking a -96.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Cost of Revenue was 740,000, a 96.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations. Social media mentions are up 59.1% in the past 24h.

Photo of The Weekly Buzzing Stocks by Billy KawasakiThe Weekly Buzzing Stocks by Billy Kawasaki
$7.36

Stock price when the opinion was issued

$12.73

As of Sep 11, 2026. Market Open.

Healthcare
Showing 1 to 2 of 2 entries
  • «
  • ‹
  • 1
  • ›
  • »

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

DASH 2.37$203.4
CAH -2.62$233.4
AMZN 3.15$255.04
GEV 32.86$956.77
CAT 11.42$816.42

Today's Top Picks

TSM 3.77$431.8
JPM 1.92$355.48
CP.TO 0.63$123.59
ZST.TO 0.02$49.08
HSAV.TO -0.1$118.27

Popular Articles

Latest Sell Signals

ORCL 0.28$153.22
URI -39.69$989.08
BBD.B.TO -3.04$302.68
BN.TO 0.48$53.12
APLD -1.36$25.78

Most Recent Experts

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automatically

MoonLake Immunotherapeutics (MLTX) Frequently Asked Questions

What is MoonLake Immunotherapeutics stock symbol?

MoonLake Immunotherapeutics is a American stock, trading under the symbol MLTX (previously MLTX-Q on Stockchase) on the NASDAQ (MLTX). It is usually referred to as NASDAQ:MLTX or MLTX

Is MoonLake Immunotherapeutics a buy or a sell?

In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on MLTX (previously MLTX-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for MoonLake Immunotherapeutics.

Is MoonLake Immunotherapeutics a good investment or a top pick?

MoonLake Immunotherapeutics was recommended as a Top Pick by The Weekly Buzzing Stocks by Billy Kawasaki on 2025-10-02. Read the latest stock experts ratings for MoonLake Immunotherapeutics.

Why is MoonLake Immunotherapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for MoonLake Immunotherapeutics.

Is MoonLake Immunotherapeutics worth watching?

MoonLake Immunotherapeutics is covered by Stockchase experts and is worth watching.

What is MoonLake Immunotherapeutics stock price?

On 2026-09-11, MoonLake Immunotherapeutics (MLTX) stock closed at a price of $12.73.